<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) is one of the most common inherited <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorders</z:e> that severely affects the cardiovascular system </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations in the gene encoding fibrillin-1 (FBN1) have been shown to cause <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> as well as dominant <z:hpo ids='HP_0001083'>ectopia lentis</z:hpo> and neonatal <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Fibrillin-1 is the major component of elastic fiber microfibrils in the extracellular matrix of connective tissue </plain></SENT>
<SENT sid="3" pm="."><plain>Recent molecular studies have brought some light into understanding the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>, but the diagnostic problems still prevail, and targeted therapy of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> must await better dissection of the role of fibrillin-1 in tissue phenotype using different experimental systems </plain></SENT>
<SENT sid="4" pm="."><plain>(Trends Cardiovasc Med 1997;7:282-288). Â© 1997, Elsevier Science Inc </plain></SENT>
</text></document>